Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cohort profile: The Australian Parkinson’s Genetics Study (APGS)

Svetlana Bivol, George D. Mellick, Jacob Gratten, Richard Parker, Aoibhe Mulcahy, Philip Mosley, Peter C. Poortvliet, Adrian I. Campos, Brittany L. Mitchell, Luis M. Garcia-Marin, Simone Cross, Mary Ferguson, Penelope A. Lind, Danuta Z. Loesch, Sarah E. Medland, Peter M. Visscher, Clemens R. Scherzer, Nicholas G. Martin, View ORCID ProfileMiguel E. Rentería
doi: https://doi.org/10.1101/2021.04.02.21254825
Svetlana Bivol
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George D. Mellick
2Griffith Institute for Drug Discovery (GRIDD), Griffith University, Brisbane, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob Gratten
3Mater Research, Translational Research Institute, Brisbane, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Parker
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aoibhe Mulcahy
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
4School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Mosley
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
5Queensland Brain Institute, The University of Queensland, Brisbane, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter C. Poortvliet
2Griffith Institute for Drug Discovery (GRIDD), Griffith University, Brisbane, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian I. Campos
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
6School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brittany L. Mitchell
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
4School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis M. Garcia-Marin
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
6School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Cross
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Ferguson
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penelope A. Lind
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
4School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia
6School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danuta Z. Loesch
7School of Psychology and Public Health, La Trobe University, Melbourne, VIC, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah E. Medland
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
8School of Psychology, University of Queensland, Brisbane, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter M. Visscher
9Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clemens R. Scherzer
10Center for Advanced Parkinson Research, Harvard Medical School and Brigham & Women’s Hospital, Boston, MA, USA
11Precision Neurology Program, Harvard Medical School and Brigham & Women’s Hospital, Boston, MA, USA
12Department of Neurology, Massachusetts General Hospital, Boston, MA, USA
13Program in Neuroscience, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas G. Martin
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel E. Rentería
1QIMR Berghofer Medical Research Institute, Brisbane QLD Australia
4School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia
6School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane QLD Australia
10Center for Advanced Parkinson Research, Harvard Medical School and Brigham & Women’s Hospital, Boston, MA, USA
14Global Brain Health Institute and Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miguel E. Rentería
  • For correspondence: miguel.renteria@qimrberghofer.edu.au
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose Parkinson’s disease (PD) is a neurodegenerative disorder associated with progressive disability. While the precise aetiology is unknown, there is evidence of significant genetic and environmental influences on individual risk. The Australian Parkinson’s Genetics Study (APGS) seeks to study patient-reported data from a large cohort of individuals with PD in Australia to understand the sociodemographic, genetic, and environmental basis of PD susceptibility, symptoms and progression.

Participants In the pilot phase reported here, 1,819 participants were recruited through assisted mailouts facilitated by Services Australia (formerly known as the Australian Government Department of Human Services), based on having three or more prescriptions for anti-PD medications in their Pharmaceutical Benefits Scheme (PBS) records. The average age at the time of the questionnaire was 64 ± 6 years. We collected patient-reported PD information and socio-demographic variables via an online (93% of the cohort) or paper-based (7%) questionnaire. 1,532 participants (84.2%) had a current PD diagnosis and consented to provide a DNA sample via a saliva sampling kit sent by traditional post. Of these, 1435 (94%) returned the saliva samples for genotyping.

Findings to date 65% of participants were male, and 92% identified as being of European descent. A previous traumatic brain injury was reported by 16% of participants and was associated with a younger age of symptom onset. At the time of the questionnaire, constipation (36% of participants), depression (34%), anxiety (17%), melanoma (16%) and diabetes (10%) were the most commonly reported comorbid conditions.

Future plans We are actively seeking funding to expand the project’s scope and reach, including recruiting unaffected controls, and a follow-up questionnaire focused on non-motor symptoms and cognitive function assessment. Future work will explore the role of genetic and environmental factors in the aetiology of PD susceptibility, onset, symptoms and progression, including as part of international PD research consortia.

Strengths and limitations of this study

  • We showed that recruiting Australian participants for PD research through the PBS database is feasible and a highly efficient method and enables us to reach people all over Australia who have been prescribed medications used to treat Parkinson’s symptoms.

  • The Australian Parkinson’s Genetics Study (APGS) is the most extensive nation-wide genetic study of Parkinson’s disease (PD) in Australia (n = 1,532 in its pilot phase). It will serve as a platform for advancing PD research in the country.

  • As part of this pilot, we collected patient-reported outcomes and variables relevant to disease onset, diagnosis, symptoms, medical comorbidities and family history. Information on environmental exposures, lifestyle factors, ethnicity and socio-demographic variables were also included.

  • A general limitation is that traditional motor-related PD symptoms can most reliably be assessed during a clinical visit. Also, patient-reported data may be subject to a degree of attribution or recall bias for items concerning the age of symptom onset or the environmental and occupational exposures.

Competing Interest Statement

CRS has collaborated with Pfizer, Opko, Proteome Sciences, Genzyme Inc; has consulted for Genzyme; has served as Advisor to the Michael J. Fox Foundation, NIH, Department of Defense; is on the Scientific Advisory Board of the American Parkinson Disease Association; has received funding from the NIH, the U.S. Department of Defense, the Harvard NeuroDiscovery Center, the Michael J. Fox Foundation, and American Parkinson Disease Association. XD has received funding from the NIH, the Michael J. Fox Foundation, and American Parkinson Disease Association.

Funding Statement

The APGS mailout was primarily funded by National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC) through an NHMRC-ARC Dementia Research Development Fellowship award to MER (GNT1102821). AIC and LMGM are supported by UQ Research Training Scholarships from The University of Queensland (UQ). JG thanks the NHMRC (1127440) and Mater Foundation for support. SEM is supported by an NHMRC Investigator grant (APP1172917).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study has been approved by the Human Research Ethics Committee of the QIMR Berghofer Medical Research Institute.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

: Data is available upon reasonable request for research purposes, in anonymised form, to preserve participants' identity. Inquiries from potential scientific collaborators can be directed to the corresponding author (Miguel.Renteria@qimrberghofer.edu.au).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 07, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cohort profile: The Australian Parkinson’s Genetics Study (APGS)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cohort profile: The Australian Parkinson’s Genetics Study (APGS)
Svetlana Bivol, George D. Mellick, Jacob Gratten, Richard Parker, Aoibhe Mulcahy, Philip Mosley, Peter C. Poortvliet, Adrian I. Campos, Brittany L. Mitchell, Luis M. Garcia-Marin, Simone Cross, Mary Ferguson, Penelope A. Lind, Danuta Z. Loesch, Sarah E. Medland, Peter M. Visscher, Clemens R. Scherzer, Nicholas G. Martin, Miguel E. Rentería
medRxiv 2021.04.02.21254825; doi: https://doi.org/10.1101/2021.04.02.21254825
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Cohort profile: The Australian Parkinson’s Genetics Study (APGS)
Svetlana Bivol, George D. Mellick, Jacob Gratten, Richard Parker, Aoibhe Mulcahy, Philip Mosley, Peter C. Poortvliet, Adrian I. Campos, Brittany L. Mitchell, Luis M. Garcia-Marin, Simone Cross, Mary Ferguson, Penelope A. Lind, Danuta Z. Loesch, Sarah E. Medland, Peter M. Visscher, Clemens R. Scherzer, Nicholas G. Martin, Miguel E. Rentería
medRxiv 2021.04.02.21254825; doi: https://doi.org/10.1101/2021.04.02.21254825

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (412)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (156)
  • Dermatology (97)
  • Emergency Medicine (247)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (392)
  • Epidemiology (8534)
  • Forensic Medicine (4)
  • Gastroenterology (381)
  • Genetic and Genomic Medicine (1739)
  • Geriatric Medicine (167)
  • Health Economics (370)
  • Health Informatics (1234)
  • Health Policy (618)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (369)
  • Infectious Diseases (except HIV/AIDS) (10271)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1666)
  • Nursing (97)
  • Nutrition (247)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (925)
  • Ophthalmology (262)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (110)
  • Palliative Medicine (40)
  • Pathology (249)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (246)
  • Primary Care Research (205)
  • Psychiatry and Clinical Psychology (1757)
  • Public and Global Health (3826)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (317)
  • Respiratory Medicine (518)
  • Rheumatology (207)
  • Sexual and Reproductive Health (164)
  • Sports Medicine (156)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (100)
  • Urology (74)